Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Etoposide × 30 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 12 Lymphoma, Large B-Cell, Diffuse 6 Lung Neoplasms 5 Burkitt Lymphoma 5 Recurrence 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Hodgkin Disease 4 Sarcoma, Ewing 3 Neoplasms 3 Lymphoma 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Ependymoma 2 Carcinoma, Embryonal 2 Waldenstrom Macroglobulinemia 1 Vasculitis, Central Nervous System 1 Urologic Neoplasms 1 Thyroid Neoplasms 1 Stiff-Person Syndrome 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Small Cell Lung Cancer Extensive Stage 1

Interventions

Nivolumab 18 cabozantinib 14 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Ipilimumab 12 pembrolizumab 11 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 trastuzumab deruxtecan 1 temsirolimus 1 sitravatinib 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡